SCHEMBL20152339

SCHEMBL20152339

Ic1ccccc1N1c2ccccc2C(c2ccccc2)(c2ccccc2)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 1/20 0.44
▸ CNR1 P21554 1/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.36
▸ LMNA P02545 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ P2RX1 P51575 1/20 0.33
▸ P2RX3 P56373 1/20 0.33
▸ P2RX4 Q99571 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29833177 0.79 ALDH1A1 (0.41) MGLLCNR1GPR55LMNAALDH1A1
SCHEMBL13231436 0.79 ALDH1A1 (0.37) MGLLCNR1GPR55LMNAALDH1A1
SCHEMBL2754763 0.79 ALDH1A1 (0.41) MGLLCNR1GPR55LMNAALDH1A1
SCHEMBL20152337 0.78 MEN1 (0.40) CNR1GPR55LMNAALDH1A1P2RX1
SCHEMBL19900154 0.78 MGLL (0.44) MGLLCNR1GPR55LMNAALDH1A1
SCHEMBL28842654 0.77 MGLL (0.47) MGLLLMNAALDH1A1GAAKDM4E
SCHEMBL19035959 0.77 LMNA (0.36) CNR1GPR55LMNAALDH1A1P2RX1
SCHEMBL20160481 0.76 LMNA (0.38) CNR1GPR55LMNAALDH1A1P2RX1
SCHEMBL20383358 0.76 ALDH1A1 (0.39) MGLLCNR1GPR55LMNAALDH1A1
SCHEMBL15030649 0.76 ALDH1A1 (0.39) MGLLCNR1GPR55LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844059-B2 Heterocyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-11-24 — — US disclosed
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 — — US disclosed
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME OR10J3, HDAC10, RBM12 MGLL 4818/4885CNR1 504/4885GPR55 1868/4885
US-10844059-B2 Heterocyclic compound and organic electroluminescence device including the same OR10J3, HDAC10, RBM12 MGLL 4818/4885CNR1 504/4885GPR55 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback